InvestorsHub Logo
Followers 14
Posts 1160
Boards Moderated 0
Alias Born 12/19/2008

Re: None

Monday, 01/12/2009 8:52:52 AM

Monday, January 12, 2009 8:52:52 AM

Post# of 58465
It's been a great few days for GNTA...

Orphan drug designation for Tesetaxel, 2 new patents, great results from the Phase III AGENDA trial...pretty incredible.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.